Literature DB >> 6172532

Monoclonal ant-idiotypic antibodies reactive with a highly conserved determinant on A/J serum anti-para-azophenylarsonate antibodies.

M J Nelles, L A Gill-Pazaris, A Nisonoff.   

Abstract

Previous reports have shown the A/J anti-para-azophenylarsonate (anti-Ar) antibodies that share a major cross-reactive idiotype (CRI) comprise a family of closely related but nonidentical molecules. Serological studies with CRI+ monoclonal anti-Ar antibodies have suggested the presence of a conserved idiotypic determinant within the family. The present study utilized monoclonal ant-idiotypic determinant within the family. The present study utilized monoclonal anti-idiotypic antibodies to define further the nature of the conserved idiotypic determinant. It was found that 8 of 10 CRI+ monoclonal antibodies possess an idiotypic determinant reactive with each of three monoclonal anti-idiotypic antibodies. In addition, approximately 60% of CRI+ serum anti-Ar antibodies reacted with one of the monoclonal anti-idiotypic preparations. The monoclonal anti-idiotypic antibodies react with an idiotope in the region of the hapten-binding site, as indicated by the ability of free haptens to inhibit idiotype-anti-idiotype interactions. Finally, two of three monoclonal anti-idiotypic antibodies suppressed the subsequent production of CRE+ serum anti-Ar antibodies when administered before antigen, without significantly affecting the total anti-Ar response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172532      PMCID: PMC2186544          DOI: 10.1084/jem.154.6.1752

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

2.  Standardization of the chloramine-T method of protein iodination.

Authors:  R Hunter
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

3.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

4.  Unique determinants associated with hybridoma proteins expressing a cross-reactive idiotype: frequency among individual immune sera.

Authors:  A Marshak-Rothstein; J D Benedetto; R L Kirsch; M L Gefter
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  An intrastrain cross-reactive idiotype associated with anti-p-azophenylarsonate antibodies of BALB/c mice.

Authors:  A R Brown; A Nisonoff
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Relationship of idiotypes of the anti-p-azophenylarsonate antibodies of A/J and BALB/c mice.

Authors:  A R Brown; E Lamoyi; A Nisonoff
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Frequency of occurrence of idiotypes associated with anti-p-azophenylarsonate antibodies arising in mice immunologically suppressed with respect to a cross-reactive idiotype.

Authors:  S Ju; A Gray; A Nisonoff
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

8.  Quantitative investigations of idiotypic antibodies. I. Analysis of precipitating antibody populations.

Authors:  H Daugharty; J E Hopper; A B MacDonald; A Nisonoff
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

9.  Presence of highly conserved idiotypic determinants in a family of antibodies that constitute an intrastrain cross-reactive idiotype.

Authors:  E Lamoyi; P Estess; J D Capra; A Nisonoff
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody.

Authors:  W R Thomas; G Morahan; I D Walker; J F Miller
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  9 in total

1.  Independent regulation of serologically distinct idiotypes in F1 hybrid mice.

Authors:  T F Kresina; M J Nelles; A Nisonoff; A R Brown
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 2.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

Review 3.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

4.  Influence of helper T cells on the expression of a murine intrastrain crossreactive idiotype.

Authors:  K S Hathcock; M F Gurish; A Nisonoff; J D Conger; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

5.  Induction of idiotope suppression in the anti-azophenylarsonate response of T-depleted A/J mice.

Authors:  T L Rothstein; R A Miller; D J Parker; E Kelly; A P Vastola; A Marshak-Rothstein
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

6.  Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced anti-p-azophenylarsonate antibodies and on endogenous antibodies not specific for arsonate.

Authors:  P V Hornbeck; G K Lewis
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

7.  Fine specificity of idiotope suppression in the A/J anti-azophenylarsonate response.

Authors:  T L Rothstein; M N Margolies; M L Gefter; A Marshak-Rothstein
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

8.  Amino acid sequence diversity within the family of antibodies bearing the major antiarsonate cross-reactive idiotype of the A strain mouse.

Authors:  C A Slaughter; J D Capra
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

9.  Passive transfer of the idiotypically suppressed state by serum from suppressed mice and transfer of suppression from mothers to offspring.

Authors:  T F Kresina; A Nisonoff
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.